Helicobacter pylori and Nonmalignant Diseases

Area of Science:

• Gastroenterology
• Microbiology

Background:

• Helicobacter pylori infection is a primary cause of peptic ulcers and functional dyspepsia.
• The relationship between H. pylori and gastroesophageal reflux disease (GERD) remains under investigation.
• H. pylori-associated peptic ulcer prevalence is decreasing, but severe complications persist, particularly in older adults.

Purpose of the Study:

• To review recent studies on H. pylori's role in peptic ulcer disease, functional dyspepsia, and GERD.
• To highlight the importance of H. pylori eradication in managing associated gastrointestinal conditions.
• To discuss the implications of H. pylori infection in patients undergoing long-term acid suppression therapy.

Main Methods:

• Literature review of recent studies on Helicobacter pylori and related gastrointestinal diseases.
• Analysis of epidemiological trends in H. pylori-associated peptic ulcer disease.
• Evaluation of the impact of H. pylori eradication on dyspepsia and GERD symptoms.
• Assessment of H. pylori's influence on gastric atrophy in patients using proton pump inhibitors.

Main Results:

• H. pylori-associated peptic ulcer incidence is declining, yet perforation and bleeding rates remain high, especially in the elderly.
• Eradication therapy is recommended for all H. pylori-associated peptic ulcers.
• Approximately 8% of individuals with functional dyspepsia experience symptom improvement following H. pylori treatment.
• Studies suggest a negative association between H. pylori and GERD, and H. pylori treatment does not appear to worsen GERD or affect medication response.
• Long-term acid suppression in H. pylori-infected patients may accelerate gastric atrophy, underscoring the need for H. pylori treatment.

Conclusions:

• H. pylori eradication is essential for managing peptic ulcer disease and offers benefits for some functional dyspepsia cases.
• The role of H. pylori in GERD is complex, but treatment is advisable for infected individuals, particularly those on long-term proton pump inhibitor therapy, to prevent gastric atrophy.